Introducing Achieve Life Sciences
Achieve Life Sciences, Inc. (Nasdaq: ACHV) is a late-stage clinical pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine dependence.
~480K
Deaths in the U.S. Annually
1.1B
Global Smokers
$300B
Annual Healthcare Costs Associated with Smoking Costs in the U.S.
Recent Announcements
ORCA Development Program
